Prescription drug · ANDA
Asprin And Extended-Release Dipyridamole NDC 68462-405
Aspirin 25 mg/1; Dipyridamole 200 mg/1 · Capsule · Oral · Glenmark Pharmaceuticals Inc., USA
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68462-405-30 | 68462040530 | 30 CAPSULE in 1 BOTTLE (68462-405-30)Marketed from May 24, 2019 | |
| 68462-405-60 | 68462040560 | 60 CAPSULE in 1 BOTTLE (68462-405-60)Marketed from May 24, 2019 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Asprin And Extended-Release Dipyridamole
- Generic name (nonproprietary)
- asprin and extended-release dipyridamole
- Active ingredients
- Aspirin — 25 mg/1Dipyridamole — 200 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 210318
- Marketing start
- Listing expires
- Other FDA classes
- Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)Decreased Platelet Aggregation (Physiologic effect)Decreased Platelet Aggregation (Physiologic effect)Decreased Prostaglandin Production (Physiologic effect)
- Identifiers
- Product ID 68462-405_d202f375-08c4-42da-bd96-2b62d7ebe7e8SPL ID d202f375-08c4-42da-bd96-2b62d7ebe7e8SPL set ID 467d6ce3-bc05-4aa1-87cc-3214fd628d39RxCUI 259081UNII R16CO5Y76E, 64ALC7F90CUPC 0368462405604
- Pharmacologic class
- Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468462040530followed by a unit qualifier and the quantityPackage 68462-0405-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. • Aspirin and extended-release dipyridamole capsules are a combination of aspirin and dipyridamole, antiplatelet agents, indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis ( 1 )
Excerpt only. Read the full label for complete information.